News

The European Commission has published the first-ever Continuous Monitoring Report for the ERNs, confirming a 160% increase in new patients referred to ERN centres between 2018 and 2024.

We are proud to take part in this landmark gathering — the largest European initiative in healthcare — bringing together leading Comprehensive Cancer Centres (CCCs) across Europe with one shared mission: To build a strong and connected network of Comprehensive Cancer Centres across Europe by 2028.

The European Commission has opened a consultation on the draft Multiannual Financial Framework (MFF) — the EU’s long-term budget plan. In the current proposal, rare cancers and rare diseases are not explicitly mentioned, and the EU4Health programme no longer appears as a standalone initiative.

EURACAN held a high-level brainstorming session that brought together leading European experts to exchange ideas and define strategic directions for advancing care and research in rare cancers.

Join the Cancer Genomic Epidemiology course, 16–18 February 2026, for an immersive look at how genomics and epidemiology intersect to advance cancer research, clinical practice, and prevention.

EURACAN is proud to support SCAN 2025 – the Survey of Challenges in Access to Diagnostics, Treatments and Care for NET Patients, launched by our partner INCA (International Neuroendocrine Cancer Alliance).

The 17th Monegasque Cancer Congress will be held from 27 to 30 January 2026 at the Grimaldi Forum in Monaco. This multidisciplinary congress will bring together more than 1,500 healthcare professionals who wish to meet and discuss developments and advances in the treatment of various cancers, as well as in haematology and pharmacy.

On July 1st, Sabine Leis from EURACAN joined 130+ passionate advocates at the European Parliament in Brussels for the Nordic Roadmap for Rare Diseases.

We’re excited to announce that the CPMS 2.0 mobile applications are now live and available to the general public on both the Apple App Store and Google Play Store!